Severity: Warning
Message: mysqli::real_connect(): (HY000/1040): Too many connections
Filename: mysqli/mysqli_driver.php
Line Number: 201
Backtrace:
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/core/MY_Controller.php
Line: 10
Function: database
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/libraries/WS_Controller.php
Line: 8
Function: __construct
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/controllers/Search.php
Line: 8
Function: __construct
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/index.php
Line: 329
Function: require_once
Severity: Warning
Message: mysqli::real_connect(): (HY000/1040): Too many connections
Filename: mysqli/mysqli_driver.php
Line Number: 201
Backtrace:
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/models/Home_model.php
Line: 7
Function: database
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/libraries/WS_Controller.php
Line: 11
Function: model
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/controllers/Search.php
Line: 8
Function: __construct
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/index.php
Line: 329
Function: require_once
Severity: Warning
Message: mysqli::real_connect(): (HY000/1040): Too many connections
Filename: mysqli/mysqli_driver.php
Line Number: 201
Backtrace:
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/models/News_model.php
Line: 7
Function: database
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/libraries/WS_Controller.php
Line: 12
Function: model
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/controllers/Search.php
Line: 8
Function: __construct
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/index.php
Line: 329
Function: require_once
Severity: Warning
Message: mysqli::real_connect(): (HY000/1040): Too many connections
Filename: mysqli/mysqli_driver.php
Line Number: 201
Backtrace:
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/models/Search_model.php
Line: 7
Function: database
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/controllers/Search.php
Line: 14
Function: model
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/index.php
Line: 329
Function: require_once
Severity: Warning
Message: mysqli::real_connect(): (HY000/1040): Too many connections
Filename: mysqli/mysqli_driver.php
Line Number: 201
Backtrace:
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/models/Videos_model.php
Line: 7
Function: database
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/controllers/Search.php
Line: 15
Function: model
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/index.php
Line: 329
Function: require_once
Severity: Warning
Message: mysqli::real_connect(): (HY000/1040): Too many connections
Filename: mysqli/mysqli_driver.php
Line Number: 201
Backtrace:
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/models/News_model.php
Line: 7
Function: database
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/application/controllers/Search.php
Line: 16
Function: model
File: /data/httpd_data/itrusoft/indianpharmapost.com/htdocs/index.php
Line: 329
Function: require_once
Intas has developed a biosimilar of Lucentis, which is currently under Phase III global trial for submission in major countries including EMA & the US
Highly prestigious award endowed with €500,000 to uphold the United Nations 2030 Agenda
The company inaugurated the new production line at the Bengaluru facility to manufacture Computed Tomography Scanners
The investment will significantly enhance the development of high-purity lipid systems, essential delivery systems for next generation nucleic acid drugs such as mRNA vaccines
Through this new set-up, the company intends to make available, affordable high-quality medical diagnostic imaging equipment across Tier 2, 3, and 4 towns in India
Company announced that it is accelerating its investment in its Leaps by Bayer impact investment unit with more than 1.3 billion euros funding until end of 2024
WHO’s post EUA inspection found deficiencies in Good Manufacturing Practice at the facility
The brand Azmarda fits well with JBCPL's overall strategy of strengthening its presence in the cardiology segment in India.
He has done his Masters in Pharmacy (M. Pharm) and Post Graduate Diploma in Personnel Management & Industrial Relations
There is also a strong synergy between Jubilant and Greencure with respect to OTC portfolio which can be explored for R&D, online acceleration and offline distribution
Subscribe To Our Newsletter & Stay Updated
